B

BlackThorn Therapeutics

2 employees

BlackThorn Therapeutics is a clinical-stage neurobehavioral health company pioneering the next generation of artificial intelligence.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Artificial Intelligence
Therapeutics

Date founded

2015

Funding rounds raised

Total raised

$76M

from 12 investors over 12 rounds

B

BlackThorn Therapeutics raised $76M on June 13, 2019

Investors: Premier Partners, Polaris Partners, Biomatics Capital, GV, ARCH Venture Partners, Scripps, Vertex Ventures HC and Mercury Fund

B

BlackThorn Therapeutics raised $8M on June 20, 2017

Investors: National Institute of Neurological Disorders and Stroke (NINDS)

B

BlackThorn Therapeutics raised $14M on January 5, 2017

Investors: GV and Biomatics Capital

B

BlackThorn Therapeutics raised $40M on October 20, 2016

Investors: ARCH Venture Partners

FAQ